Pay in 4 interest-free payments of $6.89 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Diabetologia 2003
For patients with pre-existing mild or moderate DR, the effects of GLP-1 drugs could significantly worsen this condition
Arakawa M, Mita T, Azuma K, Ebato C, Goto H, Nomiyama T et al (2010) Inhibition of monocyte adhesion to endothelial cells and attenuation of atherosclerotic lesion by a glucagon-like peptide-1 receptor agonist, exendin-4
MC1R activation by MT-1 drives cAMP-PKA signalling that upregulates nucleotide excision repair enzymes, reduces cyclobutane pyrimidine dimer formation following UV challenge, activates antioxidant defence pathways, and suppresses UV-induced inflammatory cytokine production through NF-B inhibition
t hiu qu r rt hn, c bit l ci thin sc t, c th cn 3 6 thng hoc lu hn, ty c a v tnh trng da ban u
US$ 25.04
US$ 29.86
US$ 21.59
US$ 21.82
US$ 25.13
US$ 27.46
US$ 29.57
US$ 27.69
US$ 27.05
US$ 20.05
US$ 22.56
US$ 21.55
